vimarsana.com

Latest Breaking News On - Tafenoquine arakoda - Page 1 : vimarsana.com

60 Degrees Pharmaceuticals, Inc (NASDAQ:SXTP) Sees Significant Growth in Short Interest

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP – Get Free Report) was the target of a large growth in short interest in the month of April. As of April 15th, there was short interest totalling 130,700 shares, a growth of 95.1% from the March 31st total of 67,000 shares. Currently, 1.5% of the shares of the company […]

Short Interest in 60 Degrees Pharmaceuticals, Inc (NASDAQ:SXTP) Decreases By 56 9%

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP – Get Free Report) was the target of a large decline in short interest in the month of March. As of March 15th, there was short interest totalling 65,500 shares, a decline of 56.9% from the February 29th total of 152,000 shares. Approximately 1.5% of the company’s shares are short […]

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Trading Down 3 6%

60 Degrees Pharmaceuticals (NASDAQ:SXTP) Trading Down 3 6%
kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.

Short Interest in 60 Degrees Pharmaceuticals, Inc (NASDAQ:SXTP) Drops By 50 5%

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP – Get Free Report) saw a large drop in short interest in February. As of February 15th, there was short interest totalling 255,300 shares, a drop of 50.5% from the January 31st total of 515,700 shares. Based on an average daily trading volume, of 764,700 shares, the short-interest ratio is […]

HC Wainwright Weighs in on 60 Degrees Pharmaceuticals, Inc s Q1 2024 Earnings (NASDAQ:SXTP)

60 Degrees Pharmaceuticals, Inc. (NASDAQ:SXTP – Free Report) – HC Wainwright issued their Q1 2024 earnings estimates for shares of 60 Degrees Pharmaceuticals in a report issued on Friday, February 2nd. HC Wainwright analyst E. White forecasts that the company will earn ($0.17) per share for the quarter. HC Wainwright currently has a “Neutral” rating […]

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.